HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies?
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 22802728.
- Also identified by DOI 10.1371/journal.pmed.1001232 and PMC identifier 3393667.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Universal HIV testing and immediate antiretroviral therapy for infected individuals has been proposed as a way of reducing the transmission of HIV and thereby bringing the HIV epidemic under control. It is unclear whether transmission during early HIV infection--before individuals are likely to have been diagnosed with HIV and started on antiretroviral therapy--will compromise the effectiveness of treatment as prevention. This article presents two opposing viewpoints by Powers, Miller, and Cohen, and Williams and Dye, followed by a commentary by Fraser.
Medical subject headings
- Anti-HIV Agents
- HIV Infections